Add to ORKGhigh cumulative doses of erythropoietin neuroprotective in preterm infants? A two year follow-up repor
Although recombinant human erythropoietin (rhEpo) has been shown to be neuroprotective in experiment...
We sought to determine, in very preterm infants, whether elevated perinatal erythropoietin (EPO) con...
BACKGROUND: Preterm infants suffering from intraventricular hemorrhage (IVH) are at increased risk f...
Preterm infants are at risk for neurodevelopmental sequelae even in absence of major cerebral lesion...
BACKGROUND: High-dose erythropoietin has been shown to have a neuroprotective effect in preclinical ...
Very preterm infants are at risk of developing encephalopathy of prematurity and long-term neurodeve...
Importance Premature infants are at risk of developing encephalopathy of prematurity, which is asso...
Premature infants are particularly vulnerable to brain injuries with associated cognitive and behavi...
A meta-analysis update of randomized controlled trials investigating recombinant human erythropoieti...
BackgroundHypoxic-ischemic encephalopathy (HIE) remains an important cause of neonatal death and fre...
OBJECTIVE: To investigate the safety and short term outcome of high dose recombinant human erythrop...
BackgroundErythropoietin is neuroprotective in animal models of neonatal hypoxic-ischemic encephalop...
Introduction: Preterm infants born before 28 weeks of gestation are at high risk of neurodevelopment...
Despite improved survival, many preterm infants undergo subsequent neurodevelopmental impairment. To...
Protective strategies against perinatal brain injury represent a major challenge for modern neonatol...
Although recombinant human erythropoietin (rhEpo) has been shown to be neuroprotective in experiment...
We sought to determine, in very preterm infants, whether elevated perinatal erythropoietin (EPO) con...
BACKGROUND: Preterm infants suffering from intraventricular hemorrhage (IVH) are at increased risk f...
Preterm infants are at risk for neurodevelopmental sequelae even in absence of major cerebral lesion...
BACKGROUND: High-dose erythropoietin has been shown to have a neuroprotective effect in preclinical ...
Very preterm infants are at risk of developing encephalopathy of prematurity and long-term neurodeve...
Importance Premature infants are at risk of developing encephalopathy of prematurity, which is asso...
Premature infants are particularly vulnerable to brain injuries with associated cognitive and behavi...
A meta-analysis update of randomized controlled trials investigating recombinant human erythropoieti...
BackgroundHypoxic-ischemic encephalopathy (HIE) remains an important cause of neonatal death and fre...
OBJECTIVE: To investigate the safety and short term outcome of high dose recombinant human erythrop...
BackgroundErythropoietin is neuroprotective in animal models of neonatal hypoxic-ischemic encephalop...
Introduction: Preterm infants born before 28 weeks of gestation are at high risk of neurodevelopment...
Despite improved survival, many preterm infants undergo subsequent neurodevelopmental impairment. To...
Protective strategies against perinatal brain injury represent a major challenge for modern neonatol...
Although recombinant human erythropoietin (rhEpo) has been shown to be neuroprotective in experiment...
We sought to determine, in very preterm infants, whether elevated perinatal erythropoietin (EPO) con...
BACKGROUND: Preterm infants suffering from intraventricular hemorrhage (IVH) are at increased risk f...